Loading clinical trials...
Loading clinical trials...
Efficacy and Safety Evaluation of Fractional Microneedling Radiofrequency Combined With 30% Supramolecular Salicylic Acid in the Treatment of Refractory Erythrotelangiectatic Rosacea
Conditions
Interventions
Gold micro needles
Gold micro-needles combined with salicylic acid
Locations
1
China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Start Date
December 1, 2023
Primary Completion Date
November 14, 2024
Completion Date
November 14, 2024
Last Updated
May 13, 2025
NCT04214483
NCT06873087
NCT06271135
NCT04336163
NCT05771298
NCT05094700
Lead Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions